top of page
Search

Announcing the Rejuve.Bio Crowd Sale!



Become an Investor in the Future of Artificial General Intelligence


Join the Longevity Revolution!


We are thrilled to announce the launch of Rejuve.Bio's Crowd Fund Raise on the NetCapital platform. Click here for more information. NetCapital->RejuveBio


This is an unprecedented opportunity for investors to position themselves at the forefront of Artificial General Intelligence (AGI). Rejuve.Bio is set to redefine the future of technology and quite possibly reshape the healthcare industry as we know it — and this is your chance to be a part of this upcoming technological revolution.


Rejuve.Bio is changing the course of human health and longevity through cutting-edge biotech innovation. The company harnesses the power of advanced AI and genetics to rewrite the concept of aging.


Imagine a world where living longer means living better — where age isn't a barrier, but a challenge to overcome. Rejuve.Bio's mission is to extend healthspan, redefine aging, and transform lives. Through pioneering research like our Methuselah flies project, we utilize AI to analyze and decipher complex biological data, unlocking insights crucial for advancing longevity science.


As a potential investor, you have the opportunity to be part of a groundbreaking journey that's reshaping the possibilities of human health. Join us in redefining what it means to live vibrantly and invest in a future where agelessness is within reach.


Why Invest in Rejuve.Bio?

By participating in Rejuve.Bio's Crowd Fund Raise, you have a unique chance to support the future of advanced health and longevity.


This opportunity is exceptional for several reasons, including:


1️⃣ Cutting-Edge AI Innovations: You'll be part of the select few who have the chance to contribute to the development of AI and human longevity. Rejuve.Bio harnesses advanced artificial intelligence and data analytics, uncovering groundbreaking insights into aging-related diseases, accelerating drug discovery, and developing personalized therapies. Investors can be part of revolutionary scientific advancements poised to reshape healthcare.


2️⃣ Expert Team of Visionaries: Rejuve.Bio is led by renowned professionals and boasts a staff with deep expertise in genetics, AI, and biotechnology. The company's innovative methodology, led by Kennedy Schaal and Dr. Ben Goertzel, our team includes world-class researchers, geneticists, and AI specialists like Dr. Axel Schumacher and Hedra Yusef, CTO dedicated to pioneering breakthroughs in aging research, exemplified by our Methuselah flies project. 


3️⃣ Revolutionizing Aging Paradigm: Rejuve.Bio's mission is to challenge conventional notions of aging. This is a chance for investors to not only be a part of a thriving businesses, but also an ambitious, globally beneficial mission to redefine the trajectory of human life, enhancing health, and extending vitality by converting aging from an inevitability to a treatable illness.



Don't miss this opportunity to create a better future.

Join us on our mission to unlock the true potential of AI for human healthcare and longevity. Visit Rejuve.Bio to learn more!


Visit our page on NetCapital for more information


Join the Rejuve.Bio Community: Investing in Rejuve.Bio is more than just a financial operation – it's becoming part of a global community passionate about driving AGI forward. As an investor, you gain exclusive access to our community, including regular updates, forums, events, and networking opportunities with industry leaders and experts.


 

Rejuve.Bio Inc. was founded by Ben Goertzel and has been operating on a limited scale for the majority of that time, focusing primarily on R&D and strategic longevity development, closely incubated by SingularityNET Foundation.


Disclaimer: Blog posts / Newsletters published by Rejuve.Bio are meant for informational purposes only and are not intended to serve as a recommendation to buy or sell any security in a self-directed account and are not an offer or sale of a security. Any investment is not directly managed by SingularityNET or Rejuve.Bio and NetCapital will not be managing the fund, their third-party escrow agent will manage your funds. All investments involve risk, and the past performance of a security or financial product does not guarantee future results or returns. Potential investors should seek professional advice and carefully review all documentation before making any investment decisions.


62 views0 comments

Комментарии


bottom of page